Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$733,621
-$198,606 QoQ
Shares Held
30,466
-8.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,507
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MOODY LYNN LIEBERSON & WALKER, LLC holds $207,879,465 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
81,167 | $97,354,142 | |
| 2 | ABBV |
AbbVie Inc.
|
168,964 | $42,518,100 | |
| 3 | JNJ |
Johnson & Johnson
|
134,657 | $34,198,838 | |
| 4 | MRK |
Merck & Co., Inc.
|
110,547 | $14,205,289 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
105,534 | $13,333,165 | |
| 6 | NVS |
Novartis AG
|
28,965 | $4,539,394 | |
| 7 | AMGN |
Amgen Inc
|
2,753 | $996,916 | |
| 8 | PFE |
Pfizer Inc
This page
|
30,466 | $733,621 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $733,621 | 30,466 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $932,227 | 33,199 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $663,560 | 26,649 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $679,984 | 26,687 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $716,631 | 29,564 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,186,038 | 46,805 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $1,371,601 | 51,700 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $2,406,447 | 83,153 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,565,620 | 55,955 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,185,119 | 42,707 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,301,509 | 45,207 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,934,573 | 58,323 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,562,391 | 69,858 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $12,780,436 | 313,246 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $17,294,473 | 337,519 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $15,453,493 | 353,142 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $23,319,186 | 444,768 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $20,772,246 | 401,241 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $23,800,752 | 403,061 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $9,851,569 | 229,053 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $5,030,454 | 128,459 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $4,039,355 | 111,492 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $3,781,675 | 102,735 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $2,983,743 | 81,301 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $2,511,493 | 76,804 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $2,237,501 | 68,551 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||